# B.M.K. Donato

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/b-m-k-donato/

## Facts

| Field | Value |
| --- | --- |
| Citations | 1,093 |
| Field | Health Systems, Economic Evaluations, Quality of Life |
| h-index | 14 |
| i10-index | 18 |
| Last Known Institution | Boehringer Ingelheim (United States) |
| OpenAlex ID | https://openalex.org/A5058915530 |
| ORCID iD | 0000-0001-5099-2456 |
| Works | 119 |

## Researcher papers

- [Prevalence and Overlap of Cardiac, Renal, and Metabolic Conditions in US Adults, 1999-2020](https://scholariq.org/papers/prevalence-and-overlap-of-cardiac-renal-and-metabolic-conditions-in-us-adults/)
- [Chemotherapy Use, Outcomes, and Costs for Older Persons With Advanced Non–Small-Cell Lung Cancer: Evidence From Surveillance, Epidemiology and End Results–Medicare](https://scholariq.org/papers/chemotherapy-use-outcomes-and-costs-for-older-persons-with-advanced-non-small/)
- [Patterns of use of systemic chemotherapy for Medicare beneficiaries with urothelial bladder cancer](https://scholariq.org/papers/patterns-of-use-of-systemic-chemotherapy-for-medicare-beneficiaries-with/)
- [Methods of sample size calculation in descriptive retrospective burden of illness studies](https://scholariq.org/papers/methods-of-sample-size-calculation-in-descriptive-retrospective-burden-of/)
- [Frequency and age at occurrence of clinical manifestations of disease in patients with hypophosphatasia: a systematic literature review](https://scholariq.org/papers/frequency-and-age-at-occurrence-of-clinical-manifestations-of-disease-in/)
- [The epidemiologic burden of hepatitis C virus infection in Latin America](https://scholariq.org/papers/the-epidemiologic-burden-of-hepatitis-c-virus-infection-in-latin-america/)
- [Estimated hospitalizations attributable to Diabetes Mellitus within the public healthcare system in Brazil from 2008 to 2010: study DIAPS 79](https://scholariq.org/papers/estimated-hospitalizations-attributable-to-diabetes-mellitus-within-the-public/)
- [Indirect comparison of the efficacy of cetuximab and cisplatin in squamous cell carcinoma of the head and neck](https://scholariq.org/papers/indirect-comparison-of-the-efficacy-of-cetuximab-and-cisplatin-in-squamous-cell/)
- [Custo-efetividade e impacto orçamentário da saxagliptina como terapia adicional à metformina para o tratamento do diabetes mellitus tipo 2 no sistema de saúde suplementar do Brasil](https://scholariq.org/papers/custo-efetividade-e-impacto-orcamentario-da-saxagliptina-como-terapia-adicional/)
- [Cost-effectiveness and budget impact of saxagliptine as additional therapy to metformin for the treatment of diabetes mellitus type 2 in the Brazilian private health system](https://scholariq.org/papers/cost-effectiveness-and-budget-impact-of-saxagliptine-as-additional-therapy-to/)
- [Impact of Caring for Individuals With Heart Failure in the United States](https://scholariq.org/papers/impact-of-caring-for-individuals-with-heart-failure-in-the-united-states/)

## Researcher topics

- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)

## Researcher university

- [Boehringer Ingelheim (United States)](https://scholariq.org/institutions/boehringer-ingelheim-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.